Industry: Drug Manufacturers - Specialty & Generic
CEO:Mr. Chirayu Ramanbhai Amin
Full-time employees:14593
City:Vadodara
Address:Alembic Road
IPO:2011-09-20
CIK:
Website:
General Outlook
In simple terms, Alembic Pharmaceuticals Limited has 196.563 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.711% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.100%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.096%. This tells us they're good at keeping money after all costs.
Return on Investments
Alembic Pharmaceuticals Limited's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.134%.
Stock Prices
Alembic Pharmaceuticals Limited's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $1027.35, while its low point bottomed out at $984.8. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Alembic Pharmaceuticals Limited's stock market.
Profitability Ratios
APLLTD.NS profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 9.24% underscores its earnings before tax deductions.
The effective tax rate stands at -4.43%, revealing its tax efficiency.
The net income per EBT, 104.43%, and the EBT per EBIT, 92.17%, provide insights into its earnings hierarchy.
Lastly, with an EBIT per revenue ratio of 10.02%, we grasp its operational profitability.
cards.indicator
cards.value
Pretax Profit Margin
9.24%
Effective Tax Rate
-4.43%
Net Income per EBT
104.43%
EBT per EBIT
92.17%
EBIT per Revenue
10.02%
Cash Flow Ratios
Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 28.22, and free cash flow per share, 28.22, depict cash generation on a per-share basis.
The cash per share value, 7.52, showcases liquidity position.
Lastly, the operating cash flow sales ratio, 0.09, offers insight into cash flow relative to sales.
cards.indicator
cards.value
Operating Cash Flow per Share
28.22
Free Cash Flow per Share
28.22
Cash per Share
7.52
Operating Cash Flow Sales Ratio
0.09
Free Cash Flow to Operating Cash Flow Ratio
1.00
Debt and Leverage Ratios
An interest coverage of 10.28 indicates its ability to manage interest expenses.
cards.indicator
cards.value
Interest Coverage
10.28
Growth Ratios
Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -0.84%, indicates top-line expansion, while the gross profit growth, -6.56%, reveals profitability trends.
EBIT growth, -53.57%, and operating income growth, -53.57%, offer insights into operational profitability progression.
The net income growth, -55.78%, showcases bottom-line expansion, and the EPS growth, -56.42%, measures the growth in earnings per share.
cards.indicator
cards.value
Revenue Growth
-0.84%
Gross Profit Growth
-6.56%
EBIT Growth
-53.57%
Operating Income Growth
-53.57%
Net Income Growth
-55.78%
EPS Growth
-56.42%
EPS Diluted Growth
-56.42%
Weighted Average Shares Growth
1.46%
Weighted Average Shares Diluted Growth
1.46%
Dividends per Share Growth
-1.44%
Operating Cash Flow Growth
-62.26%
Free Cash Flow Growth
-84.24%
10-Year Revenue Growth per Share
235.89%
5-Year Revenue Growth per Share
65.32%
3-Year Revenue Growth per Share
31.81%
10-Year Operating CF Growth per Share
99.95%
5-Year Operating CF Growth per Share
69.56%
3-Year Operating CF Growth per Share
-34.76%
10-Year Net Income Growth per Share
202.19%
5-Year Net Income Growth per Share
21.08%
3-Year Net Income Growth per Share
-14.50%
10-Year Shareholders Equity Growth per Share
898.30%
5-Year Shareholders Equity Growth per Share
126.25%
3-Year Shareholders Equity Growth per Share
84.75%
10-Year Dividend per Share Growth per Share
768.86%
5-Year Dividend per Share Growth per Share
190.79%
3-Year Dividend per Share Growth per Share
190.31%
Receivables Growth
47.51%
Inventory Growth
8.31%
Asset Growth
6.16%
Book Value per Share Growth
0.68%
Debt Growth
22.87%
R&D Expense Growth
99.33%
Valuation Ratios
Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 4.40, and the price to book ratio, 4.40, reflect the market's valuation relative to the company's book value.
The price to sales ratio, 3.22, provides a perspective on valuation in relation to sales.
Ratios like price to free cash flows, 35.49, and price to operating cash flows, 35.49, gauge market valuation against cash flow metrics.
cards.indicator
cards.value
Price Book Value Ratio
4.40
Price to Book Ratio
4.40
Price to Sales Ratio
3.22
Price Cash Flow Ratio
35.49
Price Earnings to Growth Ratio
0.64
Enterprise Value Multiple
21.66
Price Fair Value
4.40
Price to Operating Cash Flow Ratio
35.49
Price to Free Cash Flows Ratio
35.49
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
